DC Chemicals

All products / DC7997

ACTB-1003
CAT. NO. DC7997

ACTB-1003

Pack sizes and prices

Pack sizePrice
100 mg$700 USDRequest a quote →
250 mg$1,200 USDRequest a quote →
1 g$2,500 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

ACTB-1003 is an oral kinase inhibitor with IC50s of 6, 2 and 4 nM for FGFR1, VEGFR2 and Tie-2.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC7997
Product nameACTB-1003
CAS939805-30-8
Molecular formulaC27H26F5N7O3
Molecular weight591.5325
Purity>98%
SMILESFC1=C(C([H])=C([H])C(=C1[H])C1=C2C(N([H])[H])=NC([H])=NN2C(=C1C([H])([H])OC([H])([H])[H])C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H])N([H])C(N([H])C1=C(C([H])=C([H])C(C(F)(F)F)=C1[H])F)=O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — ACTB-1003 (DC7997)

Source references

[1]. Patel K, et al. ACTB-1003: An oral kinase inhibitor targeting cancer mutations (FGFR), angiogenesis (VEGFR2, TEK), and induction of apoptosis (RSK and p70S6K). Journal of Clinical Oncology 28, no. 15 DOI: 10.1200/jco.2010.28.15_suppl.e13665

Related research products